Gritstone bio
Biotechnology Research • 
Emeryville, California, United States • 21-50 Employees
Company overview
| Headquarters | 5858 Horton St, Emeryville, California 94608, US |
| Phone number | +15108716100 |
| Websites | |
| NAICS | 541714 |
| Keywords | Biotechnology, Oncology, Drug Development, HIV, Artificial Intelligence, Deep Learning, Machine Learning, CRC, Personalized Medicine, Immunology, Infectious Disease, Translational Medicine, Cancer Vaccines, T Cells, Colorectal Cancer, Covid-19, Mss-Crc, Epitope Discovery, Individualized Vaccine, Off-The-Shelf Cancer Vaccine, Personalized Cancer Vaccine |
| Founded | 2015 |
| Employees | 21-50 |
| Socials |
Key Contacts at Gritstone bio
Xin Zhou
Director Analytical Technologies
Wayne Robinson
Chief Executive Officer
Brendan Mcvetty
Director Of Facilities And Engineering
Michael Kroell
Senior Director Of It
Rameh Hafezi
Associate Director
Brian Evans
Director, Supply Chain, Logistics & Warehouse
Naiyer Rizvi
Member Board Of Directors
David Lachs
Associate Director
Gritstone bio Email Formats
Gritstone bio uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@gritstone.com), used 76.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@gritstone.com | 76.3% |
{first initial}{last name} | jdoe@gritstone.com | 23.7% |
About Gritstone bio
Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to develop the next-generation of vaccines for cancer and infectious disease. With our unique approach to immuno-oncology and infectious diseases, we seek to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens. We started with a focus on tumor-specific neoantigens and more recently extended our programs to include viral antigens displayed on the surface of virus-infected cells. The biology underlying immune system recognition of targets on the surface of abnormal cells is common to both anti-tumor and anti-viral immunity. Consequently, we believe that activating and directing the immune system to these targets could offer an important opportunity to extend the benefits of immunotherapy for more patients.
Gritstone bio revenue & valuation
| Annual revenue | $14,700,000 |
| Revenue per employee | $375,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $46,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Gritstone bio has 12 employees across 4 departments.
Departments
Number of employees
Funding Data
Gritstone bio has never raised funding before.
Gritstone bio Tech Stack
Discover the technologies and tools that power Gritstone bio's digital infrastructure, from frameworks to analytics platforms.
CDN
Font scripts
Accessibility
JavaScript libraries
Hosting
JavaScript libraries
Programming languages
Video players
Hosting
Blogs
JavaScript libraries
UI frameworks
Australia
Finland
India
Sweden
Saudi Arabia
Netherlands
ChinaFrequently asked questions
4.8
40,000 users
